Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326259 · ClinicalTrials.gov registry record
Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
A clinical trial, sponsored by Temple University.
- Completed
- Registry status
- 20
- Enrollment target
NCT02326259 is a clinical trial that has completed, run by Temple University. The registered enrollment target is 20 participants.
The verdict
NCT02326259 has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The investigators are doing this research for two reasons. The first is to see how the retina (back of your eye) changes when your blood sugar is treated with medication for the first time. This will help us better understand the progression of a condition known as Diabetic Retinopathy. The second reason is to provide diabetic blood samples, which will possibly help identify biomarkers for diabetic retinopathy. Biomarkers are things that indicate the presence of a specific condition, and indicate a higher likelihood of developing that condition.
Interventions
- OTHER Initiation of treatment of diabetes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-03 |
| Est. Completion | 2022-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02326259
The ClinicalTrials.gov registry entry for NCT02326259 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Initiation of treatment of diabetes is the first listed.
NCT02326259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02326259 about?
NCT02326259 is a clinical study titled "Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia". The investigators are doing this research for two reasons. The first is to see how the retina (back of your eye) changes when your blood sugar is treated with medication for the first time. This will help us better understand the progression of a condition known as Diabetic Retinopathy. The second r...
What is the current status of trial NCT02326259?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-03. Estimated completion is 2022-03.
What interventions are being tested in trial NCT02326259?
The interventions under investigation include: Initiation of treatment of diabetes (OTHER).
Who is sponsoring clinical trial NCT02326259?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.